Letter: Third‐line therapy in acute severe ulcerative colitis, exploring the uncertainty and unanswered questions
Alimentary Pharmacology & Therapeutics · 2024
DOI: 10.1111/apt.18056 ↗Kurz gefasst
Leserbrief in der Zeitschrift Alimentary Pharmacology & Therapeutics, 2024. Verfasst von J D Chetwood und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Concord Repatriation General Hospital, Concord, New South Wales, Australia. Hauptthemen laut MEDLINE: Colitis, Ulcerative. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 5 Literaturangaben.
Abstract (Originalsprache)
LINKED CONTENT This article is linked to García et al papers. To view these articles, visit https://doi.org/10.1111/apt.17938 and https://doi.org/10.1111/apt.18104 .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Concord Repatriation General Hospital, Concord, New South Wales, Australia.
- Concord Clinical School, University of Sydney, Sydney, New South Wales, Australia.
- Department of Gastroenterology, St Vincent's Hospital Melbourne, Melbourne, Victoria, Australia.
- Department of Medicine, University of Melbourne, Melbourne, Victoria, Australia.
ORCID-Profile: J D Chetwood, N S Ding
Zitieren
APA
Chetwood, J. D., & Ding, N. S. (2024). Letter: Third‐line therapy in acute severe ulcerative colitis, exploring the uncertainty and unanswered questions. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.18056
Vancouver
Chetwood JD, Ding NS. Letter: Third‐line therapy in acute severe ulcerative colitis, exploring the uncertainty and unanswered questions. Alimentary Pharmacology & Therapeutics. 2024. doi:10.1111/apt.18056
BibTeX
@article{Chetwood2024,
author = {Chetwood, J D and Ding, N S},
title = {Letter: Third‐line therapy in acute severe ulcerative colitis, exploring the uncertainty and unanswered questions},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2024},
doi = {10.1111/apt.18056}
}
EUVIMED